Was the Decision on Boosters Bungled?news2021-10-01T23:49:07+00:00October 1st, 2021|The New York Times|
Merck’s Covid Treatment Pill: What to Know About Molnupiravirnews2021-10-01T20:06:31+00:00October 1st, 2021|The New York Times|
La desinformación sobre la covid genera la escasez de ivermectina, un medicamento para animalesnews2021-09-30T15:36:21+00:00September 30th, 2021|The New York Times|
3rd Covid Vaccine Shows Side Effects Similar to 2nd Shot, C.D.C. Findsnews2021-09-28T20:31:26+00:00September 28th, 2021|The New York Times|
How the Delta Variant is Pushing Americans to Get Vaccinatednews2021-09-28T19:24:33+00:00September 28th, 2021|The New York Times|
How Covid Misinformation Created a Run on Ivermectinnews2021-09-28T09:00:22+00:00September 28th, 2021|The New York Times|
New Mexico health officials link misuse of ivermectin to two Covid-19 deaths.news2021-09-26T14:41:10+00:00September 26th, 2021|The New York Times|
W.H.O. Backs Antibody Treatment For High-Risk Covid Patientsnews2021-09-24T16:28:58+00:00September 24th, 2021|The New York Times|
C.D.C. Panel Recommends Pfizer Boosters for Many Americans, but Not Health Workersnews2021-09-23T23:32:29+00:00September 23rd, 2021|The New York Times|
Pressure Grows on U.S. Companies to Share Covid Vaccine Technologynews2021-09-22T19:23:27+00:00September 22nd, 2021|The New York Times|
